vs

Side-by-side financial comparison of Chemours Co (CC) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.

Option Care Health, Inc. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.1× Chemours Co). Option Care Health, Inc. runs the higher net margin — 4.0% vs -3.5%, a 7.5% gap on every dollar of revenue. On growth, Option Care Health, Inc. posted the faster year-over-year revenue change (8.8% vs -2.1%). Over the past eight quarters, Option Care Health, Inc.'s revenue compounded faster (13.1% CAGR vs -1.2%).

The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

CC vs OPCH — Head-to-Head

Bigger by revenue
OPCH
OPCH
1.1× larger
OPCH
$1.5B
$1.3B
CC
Growing faster (revenue YoY)
OPCH
OPCH
+10.9% gap
OPCH
8.8%
-2.1%
CC
Higher net margin
OPCH
OPCH
7.5% more per $
OPCH
4.0%
-3.5%
CC
Faster 2-yr revenue CAGR
OPCH
OPCH
Annualised
OPCH
13.1%
-1.2%
CC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CC
CC
OPCH
OPCH
Revenue
$1.3B
$1.5B
Net Profit
$-47.0M
$58.5M
Gross Margin
11.7%
19.3%
Operating Margin
6.2%
Net Margin
-3.5%
4.0%
Revenue YoY
-2.1%
8.8%
Net Profit YoY
-261.5%
-2.7%
EPS (diluted)
$-0.32
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CC
CC
OPCH
OPCH
Q4 25
$1.3B
$1.5B
Q3 25
$1.5B
$1.4B
Q2 25
$1.6B
$1.4B
Q1 25
$1.4B
$1.3B
Q4 24
$1.4B
$1.3B
Q3 24
$1.5B
$1.3B
Q2 24
$1.6B
$1.2B
Q1 24
$1.4B
$1.1B
Net Profit
CC
CC
OPCH
OPCH
Q4 25
$-47.0M
$58.5M
Q3 25
$46.0M
$51.8M
Q2 25
$-380.0M
$50.5M
Q1 25
$-5.0M
$46.7M
Q4 24
$-13.0M
$60.1M
Q3 24
$-32.0M
$53.9M
Q2 24
$60.0M
$53.0M
Q1 24
$54.0M
$44.8M
Gross Margin
CC
CC
OPCH
OPCH
Q4 25
11.7%
19.3%
Q3 25
15.6%
19.0%
Q2 25
17.2%
19.0%
Q1 25
17.3%
19.7%
Q4 24
19.4%
21.3%
Q3 24
19.0%
20.1%
Q2 24
19.8%
20.3%
Q1 24
20.9%
20.8%
Operating Margin
CC
CC
OPCH
OPCH
Q4 25
6.2%
Q3 25
2.5%
5.9%
Q2 25
-15.4%
5.8%
Q1 25
5.9%
Q4 24
-0.1%
6.9%
Q3 24
-2.1%
6.7%
Q2 24
4.4%
6.6%
Q1 24
5.1%
6.0%
Net Margin
CC
CC
OPCH
OPCH
Q4 25
-3.5%
4.0%
Q3 25
3.1%
3.6%
Q2 25
-23.5%
3.6%
Q1 25
-0.4%
3.5%
Q4 24
-1.0%
4.8%
Q3 24
-2.1%
4.2%
Q2 24
3.9%
4.3%
Q1 24
4.0%
3.9%
EPS (diluted)
CC
CC
OPCH
OPCH
Q4 25
$-0.32
$0.37
Q3 25
$0.31
$0.32
Q2 25
$-2.53
$0.31
Q1 25
$-0.03
$0.28
Q4 24
$-0.07
$0.36
Q3 24
$-0.22
$0.31
Q2 24
$0.39
$0.30
Q1 24
$0.36
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CC
CC
OPCH
OPCH
Cash + ST InvestmentsLiquidity on hand
$670.0M
$232.6M
Total DebtLower is stronger
$4.1B
Stockholders' EquityBook value
$250.0M
$1.3B
Total Assets
$7.4B
$3.5B
Debt / EquityLower = less leverage
16.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CC
CC
OPCH
OPCH
Q4 25
$670.0M
$232.6M
Q3 25
$613.0M
$309.8M
Q2 25
$502.0M
$198.8M
Q1 25
$464.0M
$171.4M
Q4 24
$713.0M
$412.6M
Q3 24
$596.0M
$483.0M
Q2 24
$604.0M
$376.9M
Q1 24
$746.0M
$219.5M
Total Debt
CC
CC
OPCH
OPCH
Q4 25
$4.1B
Q3 25
$4.1B
$1.2B
Q2 25
$4.1B
$1.1B
Q1 25
$4.1B
$1.1B
Q4 24
$4.1B
$1.1B
Q3 24
$4.0B
$1.1B
Q2 24
$4.0B
$1.1B
Q1 24
$4.0B
$1.1B
Stockholders' Equity
CC
CC
OPCH
OPCH
Q4 25
$250.0M
$1.3B
Q3 25
$274.0M
$1.4B
Q2 25
$228.0M
$1.4B
Q1 25
$566.0M
$1.4B
Q4 24
$571.0M
$1.4B
Q3 24
$643.0M
$1.4B
Q2 24
$714.0M
$1.4B
Q1 24
$753.0M
$1.4B
Total Assets
CC
CC
OPCH
OPCH
Q4 25
$7.4B
$3.5B
Q3 25
$7.5B
$3.5B
Q2 25
$7.5B
$3.4B
Q1 25
$7.4B
$3.3B
Q4 24
$7.5B
$3.4B
Q3 24
$7.5B
$3.4B
Q2 24
$7.2B
$3.3B
Q1 24
$8.0B
$3.2B
Debt / Equity
CC
CC
OPCH
OPCH
Q4 25
16.40×
Q3 25
14.96×
0.86×
Q2 25
17.99×
0.82×
Q1 25
7.18×
0.82×
Q4 24
7.11×
0.79×
Q3 24
6.20×
0.78×
Q2 24
5.53×
0.79×
Q1 24
5.27×
0.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CC
CC
OPCH
OPCH
Operating Cash FlowLast quarter
$137.0M
$258.4M
Free Cash FlowOCF − Capex
$92.0M
FCF MarginFCF / Revenue
6.9%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
4.42×
TTM Free Cash FlowTrailing 4 quarters
$51.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CC
CC
OPCH
OPCH
Q4 25
$137.0M
$258.4M
Q3 25
$146.0M
$139.4M
Q2 25
$93.0M
$90.3M
Q1 25
$-112.0M
$-7.2M
Q4 24
$138.0M
$36.1M
Q3 24
$139.0M
$160.4M
Q2 24
$-620.0M
$195.7M
Q1 24
$-290.0M
$-68.8M
Free Cash Flow
CC
CC
OPCH
OPCH
Q4 25
$92.0M
Q3 25
$105.0M
$130.2M
Q2 25
$50.0M
$81.2M
Q1 25
$-196.0M
$-16.6M
Q4 24
$29.0M
$25.8M
Q3 24
$63.0M
$150.7M
Q2 24
$-693.0M
$185.9M
Q1 24
$-392.0M
$-74.6M
FCF Margin
CC
CC
OPCH
OPCH
Q4 25
6.9%
Q3 25
7.0%
9.1%
Q2 25
3.1%
5.7%
Q1 25
-14.3%
-1.2%
Q4 24
2.1%
2.0%
Q3 24
4.2%
11.8%
Q2 24
-44.6%
15.1%
Q1 24
-28.8%
-6.5%
Capex Intensity
CC
CC
OPCH
OPCH
Q4 25
3.4%
Q3 25
2.7%
0.6%
Q2 25
2.7%
0.6%
Q1 25
6.1%
0.7%
Q4 24
8.0%
0.8%
Q3 24
5.0%
0.8%
Q2 24
4.7%
0.8%
Q1 24
7.5%
0.5%
Cash Conversion
CC
CC
OPCH
OPCH
Q4 25
4.42×
Q3 25
3.17×
2.69×
Q2 25
1.79×
Q1 25
-0.15×
Q4 24
0.60×
Q3 24
2.98×
Q2 24
-10.33×
3.69×
Q1 24
-5.37×
-1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CC
CC

Titanium Technologies$563.0M42%
Thermal And Specialized Solutions$443.0M33%
Advanced Performance Materials$312.0M23%
Other Non-Reportable Segment$12.0M1%

OPCH
OPCH

Segment breakdown not available.

Related Comparisons